Calcium-regulatory proteins as modulators of chemotherapy in human neuroblastoma

Ana Maria Florea, Elizabeth Varghese, Jennifer E. McCallum, Safa Mahgoub, Irfan Helmy, Sharon Varghese, Neha Gopinath, Steffen Sass, Fabian J. Theis, Guido Reifenberger, Dietrich Busselberg

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Neuroblastoma (NB) is a pediatric cancer treated with poly-chemotherapy including platinum complexes (e.g. cisplatin (CDDP), carboplatin), DNA alkylating agents, and topoisomerase I inhibitors (e.g. topotecan (TOPO)). Despite aggressive treatment, NB may become resistant to chemotherapy. We investigated whether CDDP and TOPO treatment of NB cells interacts with the expression and function of proteins involved in regulating calcium signaling. Human neuroblastoma cell lines SH-SY5Y, IMR-32 and NLF were used to investigate the effects of CDDP and TOPO on cell viability, apoptosis, calcium homeostasis, and expression of selected proteins regulating intracellular calcium concentration ([Ca2+]i). In addition, the impact of pharmacological inhibition of [Ca2+]i-regulating proteins on neuroblastoma cell survival was studied. Treatment of neuroblastoma cells with increasing concentrations of CDDP (0.1-10 μM) or TOPO (0.1 nM-1 μM) induced cytotoxicity and increased apoptosis in a concentration- and time-dependent manner. Both drugs increased [Ca2+]i over time. Treatment with CDDP or TOPO also modified mRNA expression of selected genes encoding [Ca2+]i-regulating proteins. Differentially regulated genes included S100A6, ITPR1, ITPR3, RYR1 and RYR3. With FACS and confocal laser scanning microscopy experiments we validated their differential expression at the protein level. Importantly, treatment of neuroblastoma cells with pharmacological modulators of [Ca2+]i-regulating proteins in combination with CDDP or TOPO increased cytotoxicity. Thus, our results confirm an important role of calcium signaling in the response of neuroblastoma cells to chemotherapy and suggest [Ca2+]i modulation as a promising strategy for adjunctive treatment.

Original languageEnglish
Pages (from-to)22876-22893
Number of pages18
JournalOncotarget
Volume8
Issue number14
DOIs
Publication statusPublished - 2017

    Fingerprint

Keywords

  • Calcium signaling
  • Chemotherapy
  • Cisplatin
  • Neuroblastoma
  • Topotecan

ASJC Scopus subject areas

  • Oncology

Cite this

Florea, A. M., Varghese, E., McCallum, J. E., Mahgoub, S., Helmy, I., Varghese, S., Gopinath, N., Sass, S., Theis, F. J., Reifenberger, G., & Busselberg, D. (2017). Calcium-regulatory proteins as modulators of chemotherapy in human neuroblastoma. Oncotarget, 8(14), 22876-22893. https://doi.org/10.18632/oncotarget.15283